Physician

Jason I Rubin, MD

According to 2025 Medicare claims, Jason Rubin, MD (NPI: 1376703090) practices hematology/oncology in the Kiryas Joel-Poughkeepsie-Newburgh, NY market, with the plurality of this provider's patient population coming from Dutchess, NY. This provider's primary affiliated billing organization is OPTUM MEDICAL CARE, P.C. (NPI: 1982643003; TIN: 133544120) and primary practice location at 12524-9998. Rubin is affiliated with the CareMount Value Partners IPA (ACO ID: D0019), participating under the REACH model.

Rubin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 685 traditional Medicare patients, billed 208,635 HCPCS/CPT codes, and received $2,980,979 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,353 prescription claims across 336 beneficiaries totaling $7,646,852 in drug costs, led by Lenalidomide (Lenalidomide). 2023 DME data shows 30 claims. Open Payments data shows 6 records totaling $126. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $442,497 to $2,980,979. Similarly, Part D prescription costs have risen steadily, from $1,915,102 to $7,646,852. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	406	42,330	$442,497
2016	448	52,475	$454,806
2017	532	85,715	$902,869
2018	692	88,117	$1,478,823
2019	710	106,331	$1,466,042
2020	709	149,016	$1,879,767
2021	757	228,846	$3,917,633
2022	757	167,791	$2,747,478
2023	666	202,592	$3,075,971
2024	685	208,635	$2,980,979

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	199	1,696	$1,915,102
2016	248	2,038	$3,129,288
2017	281	1,978	$3,047,225
2018	314	2,146	$4,115,498
2019	323	2,146	$5,154,819
2020	314	2,087	$4,832,385
2021	310	2,145	$4,828,105
2022	316	2,058	$5,204,392
2023	315	1,951	$5,296,272
2024	336	2,353	$7,646,852

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	11	72	$8,036
2016	N/R	31	$574
2017	N/R	47	$14,180
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	25	$787
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	30	$7,009
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	222	494	$103
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	317	406	$69
80053	Blood test, comprehensive group of blood chemicals	243	753	$10
36415	Insertion of needle into vein for collection of blood sample	432	1,581	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	355	1,235	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lenalidomide	Lenalidomide	68	1,890	$880,524
Imbruvica	Ibrutinib	55	1,540	$871,840
Jakafi	Ruxolitinib Phosphate	45	1,350	$757,172
Brukinsa	Zanubrutinib	52	1,560	$604,466
Darzalex Faspro	Daratumumab-Hyaluronidase-Fihj	33	924	$380,977

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$126	Daiichi Sankyo Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jason I. Rubin, MD?

Tedicare shows public-source Medicare data for Jason I. Rubin, MD (NPI 1376703090), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jason I. Rubin, MD have ACO affiliation data?

Jason I. Rubin, MD is shown with ACO affiliation data for CareMount Value Partners IPA (REACH, ACO ID D0019).

What billing organization is linked to Jason I. Rubin, MD?

Jason I. Rubin, MD is linked to OPTUM MEDICAL CARE, P.C. (billing NPI 1982643003) in the available physician profile data.

Does Jason I. Rubin, MD have Open Payments data?

Jason I. Rubin, MD has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.